Halting The Spread Of Hiv Aids

The AIDS epidemic in Sub-Saharan Africa continues to affect all facets of life throughout the subcontinent. Deaths related to AIDS have driven down the life expectancy rate of residents in Zambia, Kenya, and Uganda with far-reaching implications. This book details the current state of the AIDS epidemic in Africa and what is known about the behaviors that contribute to the transmission of the HIV infection. It lays out what research is needed and what is necessary to design more effective prevention programs.

Witnesses: Paula Dobriansky, U.S. Dept. of State; Princeton Lyman, working group co-chair, CSIS, Task Force on HIV/AIDS, Global Interdependence Initiative, Aspen Inst.; Andrew Natsios, USAID; Petrer Okaalet, Med. Assist. Program Internat.; Peter Piot, UNAIDS; Sunanda Ray, Southern Africa AIDS Info. Dissem. Service; Tommy Thompson, Sec., HHS, accomp. by Claude Allen, Deputy Sec.; Jim Yong Kim, Program in Infectious Disease & Social Change, Harvard Med. School; Eugene McCray, Global AIDS Program, Nat. Center for HIV, STD, & TB Prevention, CDC; E. Anne Peterson, Bureau of Global Health, USAID: Jeffrey Sachs, Center for Internat. Develop., Harvard Univ.; & Martin Vorster, Mahyeno Tributary Mamelodi, Pretoria, South Africa.

During the early years of the AIDS epidemic, thousands of Americans became infected with HIV through the nation's blood supply. Because little reliable information existed at the time AIDS first began showing up in hemophiliacs and in others who had received transfusions, experts disagreed about whether blood and blood products could transmit the disease. During this period of great uncertainty, decision-making regarding the blood supply became increasingly difficult and fraught with risk. This volume provides a balanced inquiry into the blood safety controversy, which involves private sexual practices, personal tragedy for the victims of HIV/AIDS, and public confidence in America's blood services system. The book focuses on critical decisions as information about the danger to the blood supply emerged. The committee draws conclusions about what was doneâ€"and recommends what should be done to produce better outcomes in the face of future threats to blood safety. The committee frames its analysis around four critical area: Product treatmentâ€"Could effective methods for inactivating HIV in blood have been introduced sooner? Donor screening and referralâ€"including a review of screening to exlude high-risk individuals. Regulations and recall of contaminated bloodâ€"analyzing decisions by federal agencies and the private sector. Risk communicationâ€"examining whether infections could have been averted by better communication of the risks.

-The latest "buzz word" in HIV prevention -Few resources available on "positive prevention" -Kalichman is a known and recognized name in the field of HIV prevention

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.